RT Journal Article
SR Electronic
T1 Dys-synchronous Regulation of XPC and XPA in Trigeminal Ganglion Neurons following Cisplatin Treatment Cycles
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 2637
OP 2640
VO 28
IS 5A
A1 GUTHRIE, O'NEIL W.
YR 2008
UL http://ar.iiarjournals.org/content/28/5A/2637.abstract
AB Background: Cancer cells may survive cis-diamminedichloroplatinum-II (cisplatin) DNA damage through synchronous mobilization of DNA repair proteins such as xeroderma pigmentosum C and A (XPC and XPA). However, non-cancerous neuronal cells exhibit hyper-vulnerability to cisplatin which is manifest as peripheral neurotoxicity. The purpose of the present study was to evaluate the effect of cisplatin on the immunolocalization of XPC and XPA in the trigeminal ganglion. Materials and Methods: Fischer344 rats were treated with two cycles of cisplatin (2 mg/kg/day, i.p.) and tissues were harvested for immunohistochemistry after each treatment cycle. Result: XPA immunoreactivity was evident after each treatment cycle, however, XPC immunoreactivity was suppressed following the second treatment cycle. Conclusion: The hyper-vulnerability of peripheral neurons to cisplatin chemotherapy may relate to the dys-synchronous regulation of XPC and XPA.